H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma
Neuro-Oncology: The Podcast · Dr. Iyad Alnahhas, Dr. Carl Koschmann
March 25, 202222m 2s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022.